IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 6450 participants.

Also called NCT06118840

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 6,450 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06118840
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06118840. Randomized; quadruple masking; primary purpose diagnostic. Start 2024-05-20 (actual); primary completion 2026-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
Acronym
IDEAL
Condition
Intracranial Aneurysm
Condition
CT Angiography
Condition
Deep Learning
Condition
Double Bind Interaction
Intervention (Device)
True-AI-integrated intracranial aneurysms diagnosis strategy
Intervention (Device)
Sham-AI-integrated intracranial aneurysms diagnosis strategy
Lead sponsor
Jinling Hospital, China (class: other)

Record details

Record id
cardio:ct-nct06118840
Content hash
7bf0defb8dceb040aaf194ab52906f2e8bb99e61391bef7063f0669c9a5f651e